Medical Disclaimer
  • For Educational Purposes Only: This content is intended for educational reference and should not be used for clinical decision-making.
  • Not a Substitute for Professional Judgment: Always consult your local protocols, institutional guidelines, and supervising physicians.
  • Accuracy Not Guaranteed: While all content has been prepared to the best of my knowledge and ability, errors or omissions may exist.
  • Verify Before Acting: Users are responsible for verifying information through authoritative sources before any clinical application.
AI Assistance Notice
The clinical content and references are curated and reviewed by myself; however, AI was used to assist in organizing, paraphrasing, and formatting the information presented.
Quick Reference
  • Normal Range: 35-45 mmHg
  • Hypercapnia: >45 mmHg (elevated PaCO2)
  • Hypocapnia: <35 mmHg (decreased PaCO2)
  • SI Units: 4.7-6.0 kPa (conversion: mmHg × 0.133 = kPa)
  • Primary Use: Assessment of ventilation and respiratory acid-base status
  • Sample Type: Arterial blood (typically radial artery)
  • Key Point: Inverse relationship with pH - as PaCO2 rises, pH falls (acidosis)

Test Description

PaCO2 (partial pressure of arterial carbon dioxide) measures the pressure exerted by dissolved carbon dioxide in arterial blood. It is the primary indicator of alveolar ventilation and represents the respiratory component of acid-base balance. Carbon dioxide is the end product of cellular metabolism and is eliminated through the lungs via ventilation.

PaCO2 has an inverse relationship with alveolar ventilation: hypoventilation leads to CO2 retention (hypercapnia), while hyperventilation leads to CO2 elimination (hypocapnia). This parameter is critical for diagnosing respiratory acid-base disorders and assessing the adequacy of ventilation in both spontaneously breathing patients and those on mechanical ventilation.

Physiological Role

  • Respiratory acid-base regulation: CO2 combines with water to form carbonic acid (H2CO3), which dissociates to H+ and HCO3-
  • Ventilatory drive: Central chemoreceptors respond to changes in PaCO2, stimulating or suppressing respiratory effort
  • Compensation mechanism: Kidneys adjust bicarbonate retention or excretion in response to chronic PaCO2 changes
  • Cerebrovascular regulation: PaCO2 is a potent regulator of cerebral blood flow
Alveolar Ventilation Equation: PaCO2 = (VCO2 × K) / VA
Where VCO2 = CO2 production, VA = alveolar ventilation, K = constant. This shows PaCO2 is inversely related to alveolar ventilation.
Normal Ranges

Normal PaCO2 values are remarkably consistent across most populations. Values outside the normal range indicate ventilatory dysfunction or respiratory compensation for metabolic disorders.

Swipe to see more
Population Normal Range (mmHg) SI Units (kPa)
Adults (all sexes) 35-45 mmHg 4.7-6.0 kPa
Pregnant Women 27-32 mmHg (physiologic hyperventilation) 3.6-4.3 kPa
Neonates 27-40 mmHg 3.6-5.3 kPa
Important Considerations:
  • Temperature correction: ABG machines measure at 37°C; hypothermia/hyperthermia affects actual PaCO2
  • Chronic compensation: COPD patients may have chronically elevated PaCO2 (50-60 mmHg) as their "normal"
  • Pregnancy adaptation: Progesterone-induced hyperventilation lowers baseline PaCO2 in pregnancy
  • Sample handling: Exposure to air or delayed analysis can falsely lower PaCO2
Clinical Significance

Elevated PaCO2 (Hypercapnia, >45 mmHg)

Hypercapnia indicates inadequate alveolar ventilation (hypoventilation) and causes respiratory acidosis. The severity and acuity determine clinical presentation and urgency of intervention.

Pulmonary Causes - Impaired Gas Exchange

  • COPD exacerbation: Most common cause; chronic air trapping and V/Q mismatch
  • Severe asthma: Exhaustion and respiratory muscle fatigue leading to hypoventilation
  • Pneumonia: Alveolar filling and shunting reduces effective ventilation
  • Pulmonary edema: Cardiogenic or non-cardiogenic (ARDS)
  • Pulmonary fibrosis: Advanced restrictive disease with limited tidal volumes

Central Nervous System - Decreased Respiratory Drive

  • Opioid overdose: Suppression of medullary respiratory centers
  • Benzodiazepine overdose: Respiratory depression, especially when combined with opioids
  • CNS injury: Traumatic brain injury, stroke affecting brainstem respiratory centers
  • Severe hypothyroidism: Myxedema coma with blunted ventilatory drive

Neuromuscular Disorders - Respiratory Muscle Weakness

  • Myasthenia gravis: Progressive weakness of respiratory muscles
  • Guillain-Barré syndrome: Ascending paralysis affecting diaphragm
  • ALS (Amyotrophic Lateral Sclerosis): Progressive motor neuron degeneration
  • Muscular dystrophy: Chronic progressive respiratory muscle weakness
  • High spinal cord injury: Loss of innervation to respiratory muscles

Mechanical/Airway Obstruction

  • Upper airway obstruction: Foreign body, angioedema, epiglottitis
  • Obesity hypoventilation syndrome: Pickwickian syndrome with chronic CO2 retention
  • Obstructive sleep apnea: Severe cases with daytime hypercapnia

Decreased PaCO2 (Hypocapnia, <35 mmHg)

Hypocapnia results from hyperventilation and causes respiratory alkalosis. May be a physiologic compensation for metabolic acidosis or a primary respiratory disorder.

Physiologic/Psychological Causes

  • Anxiety/panic attack: Psychogenic hyperventilation
  • Pain: Acute pain stimulus increases respiratory rate
  • Pregnancy: Progesterone-induced hyperventilation (physiologic)
  • High altitude: Hypoxemia-driven compensatory hyperventilation

Hypoxemia-Driven Hyperventilation

  • Pulmonary embolism: V/Q mismatch and hypoxemia trigger hyperventilation
  • Pneumonia: Early stages before respiratory fatigue
  • Interstitial lung disease: Hypoxemia and increased work of breathing
  • Pneumothorax: Acute hypoxemia and pleuritic pain

Central Nervous System Stimulation

  • Sepsis/SIRS: Cytokine-mediated hyperventilation
  • Hepatic encephalopathy: Direct CNS stimulation of respiratory center
  • Salicylate toxicity: Direct stimulation of medullary respiratory centers
  • CNS infection: Meningitis, encephalitis

Metabolic Acidosis Compensation

  • Diabetic ketoacidosis (DKA): Kussmaul respirations to blow off CO2
  • Lactic acidosis: Shock states, sepsis, metformin toxicity
  • Renal failure: Uremic acidosis with compensatory hyperventilation
  • Toxic ingestions: Methanol, ethylene glycol causing high anion gap acidosis

Iatrogenic

  • Mechanical ventilation: Excessive minute ventilation settings
  • Over-correction during resuscitation: Aggressive bag-valve-mask ventilation
Critical Values: PaCO2 >60 mmHg or rapidly rising CO2 suggests impending respiratory failure. Consider immediate intervention including possible intubation.
Interpretation Guidelines

Acute vs Chronic Respiratory Acidosis

Distinguishing acute from chronic respiratory acidosis is critical for appropriate management. The kidneys require 3-5 days to fully compensate by retaining bicarbonate.

Swipe to see more
Condition PaCO2 HCO3- Change pH Change
Acute Respiratory Acidosis Elevated +1 mEq/L per 10 mmHg ↑ PaCO2 -0.08 per 10 mmHg ↑ PaCO2
Chronic Respiratory Acidosis Elevated +3-4 mEq/L per 10 mmHg ↑ PaCO2 -0.03 per 10 mmHg ↑ PaCO2
Acute Respiratory Alkalosis Decreased -2 mEq/L per 10 mmHg ↓ PaCO2 +0.08 per 10 mmHg ↓ PaCO2
Chronic Respiratory Alkalosis Decreased -4-5 mEq/L per 10 mmHg ↓ PaCO2 +0.03 per 10 mmHg ↓ PaCO2

Expected Compensation Formulas

Winter's Formula (Metabolic Acidosis Compensation)
Expected PaCO2 = (1.5 × HCO3-) + 8 ± 2

Interpretation:
  • If measured PaCO2 matches expected: appropriate respiratory compensation
  • If measured PaCO2 > expected: concurrent respiratory acidosis
  • If measured PaCO2 < expected: concurrent respiratory alkalosis
Metabolic Alkalosis Compensation
Expected PaCO2 increase = 0.7 × (HCO3- - 24)
Or: PaCO2 increases by 6 mmHg for every 10 mEq/L increase in HCO3-

PaCO2 and pH Relationship

Inverse Relationship: For every 10 mmHg acute change in PaCO2, pH changes by approximately 0.08 in the opposite direction.
  • PaCO2 ↑ 10 mmHg → pH ↓ 0.08 (acute respiratory acidosis)
  • PaCO2 ↓ 10 mmHg → pH ↑ 0.08 (acute respiratory alkalosis)
  • Chronic changes show less pH change due to metabolic compensation

Clinical Assessment of Ventilation

Swipe to see more
PaCO2 Range Ventilation Status Clinical Implications
<25 mmHg Severe hyperventilation Risk of cerebral vasoconstriction, tetany, arrhythmias
25-35 mmHg Mild-moderate hyperventilation Assess for metabolic acidosis, anxiety, pain, hypoxemia
35-45 mmHg Normal ventilation Adequate alveolar ventilation
45-60 mmHg Mild hypoventilation May be chronic baseline in COPD or acute deterioration
>60 mmHg Severe hypoventilation Consider mechanical ventilation; risk of CO2 narcosis
Interfering Factors

Pre-analytical Factors (Sample Collection and Handling)

  • Air bubbles in syringe: CO2 diffuses into air bubbles, falsely lowering PaCO2
  • Delayed analysis: Cellular metabolism continues in sample, increasing PaCO2 over time
  • Inadequate anticoagulation: Clotting can alter gas values
  • Venous sample contamination: Venous blood has higher PaCO2 (~46 mmHg), falsely elevates result
  • Temperature: Sample analyzed at 37°C; patient hypothermia/hyperthermia requires correction

Medications That Can Increase PaCO2

  • Opioids: Morphine, fentanyl, hydrocodone - respiratory center depression
  • Benzodiazepines: Diazepam, lorazepam, midazolam - especially with opioids
  • Barbiturates: Phenobarbital - CNS and respiratory depression
  • Sedative-hypnotics: Propofol, dexmedetomidine in high doses
  • Neuromuscular blockers: If ventilation not adequately supported

Medications That Can Decrease PaCO2

  • Salicylates: Aspirin overdose - direct medullary stimulation
  • Progesterone: Increases ventilatory drive (pregnancy effect)
  • Catecholamines: Epinephrine, norepinephrine - increased respiratory rate
  • Methylxanthines: Theophylline, caffeine - respiratory stimulation

Physiological Factors

  • Fever: Increased metabolic rate and CO2 production
  • Hypothermia: Decreased metabolic rate and CO2 production
  • Exercise: Increased CO2 production, but usually compensated by increased ventilation
  • Seizures: Marked increase in CO2 production from muscle activity

Technical Issues

  • Improper sample storage: Samples must be kept on ice if analysis delayed
  • Syringe material: Plastic syringes allow slow gas diffusion; glass preferred for delayed analysis
  • Excess heparin: Dilutional effect can slightly lower all values
Clinical Pearls
"PaCO2 is the respiratory component": In acid-base interpretation, always identify PaCO2 as the respiratory parameter. If pH and PaCO2 move in opposite directions, think respiratory disorder (high CO2 = low pH = acidosis). If they move in the same direction, think metabolic disorder with respiratory compensation.
"For every 10 mmHg change in PaCO2, pH changes by 0.08 (acute)": This rule helps assess if compensation is appropriate. In acute changes, a PaCO2 of 60 mmHg (20 above normal 40) should drop pH by ~0.16 from baseline 7.40 to approximately 7.24. If pH is significantly different, suspect a mixed disorder.
Chronic compensation takes 3-5 days: Renal compensation for respiratory disorders is slow. If a patient with high PaCO2 has a near-normal pH with elevated bicarbonate, this suggests chronic respiratory acidosis (like COPD) rather than acute respiratory failure. Acute-on-chronic changes are common in COPD exacerbations.
Winter's formula is your friend: In metabolic acidosis, use Winter's formula [Expected PaCO2 = (1.5 × HCO3-) + 8 ± 2] to determine if respiratory compensation is appropriate. If the measured PaCO2 is higher than expected, there's a concurrent respiratory acidosis. If lower, there's a respiratory alkalosis.
Respiratory compensation is fast (minutes to hours): Unlike metabolic compensation which takes days, respiratory compensation for metabolic disorders occurs rapidly. In metabolic acidosis, expect hyperventilation and low PaCO2 within minutes. If PaCO2 is normal or high in severe metabolic acidosis, this is concerning for respiratory muscle fatigue or failure.
Beware the "normal" PaCO2 in severe acidosis: A patient in severe DKA (pH 7.10, HCO3- 8) with a PaCO2 of 40 mmHg (normal range) is actually in respiratory failure. Winter's formula predicts PaCO2 should be ~20 mmHg. A "normal" PaCO2 here indicates inability to compensate and impending respiratory arrest - consider early intubation.
COPD patients and oxygen: Many COPD patients with chronic CO2 retention rely on hypoxic drive for ventilation. However, the fear of oxygen-induced hypercapnia should NEVER prevent adequate oxygenation. Give oxygen to maintain SpO2 88-92% in COPD; monitor closely with repeat ABGs if concerned about worsening hypercapnia.
PaCO2 trends matter more than single values: Serial ABGs showing rising PaCO2 with falling pH indicate worsening respiratory failure and may prompt intubation. A patient with PaCO2 of 60 who is alert, protecting airway, and stable may not need intubation, but one with PaCO2 rising from 45 to 60 over 2 hours with altered mental status likely does.
Post-intubation hyperventilation trap: After intubating a patient with severe metabolic acidosis and compensatory hyperventilation, DO NOT normalize their PaCO2 to 40 mmHg with mechanical ventilation. Maintain their low PaCO2 (match their pre-intubation minute ventilation) to avoid sudden severe acidemia and cardiovascular collapse.
The A-a gradient helps differentiate: Calculate the A-a gradient [A-a = PAO2 - PaO2, where PAO2 = (FiO2 × [Patm - 47]) - (PaCO2/0.8)]. A normal A-a gradient with hypoxemia and hypercapnia suggests hypoventilation (drug overdose, neuromuscular disease). An elevated A-a gradient suggests V/Q mismatch or shunt (pneumonia, PE, ARDS).
Don't forget the clinical context: Always correlate PaCO2 with clinical presentation. A lethargic patient with PaCO2 of 70 mmHg and no history of COPD is in acute respiratory failure requiring immediate intervention. The same PaCO2 in an alert COPD patient with chronic retention may be their baseline - check old records if available.
References
  1. Kratz, A., Ferraro, M., Sluss, P. M., & Lewandrowski, K. B. (2004). Laboratory reference values. New England Journal of Medicine, 351, 1548-1564.
  2. Lee, M. (Ed.). (2009). Basic skills in interpreting laboratory data. Ashp.
  3. Farinde, A. (2021). Lab values, normal adult: Laboratory reference ranges in healthy adults. Medscape. https://emedicine.medscape.com/article/2172316-overview
  4. Nickson, C. (n.d.). Critical Care Compendium. Life in the Fast Lane • LITFL. https://litfl.com/ccc-critical-care-compendium/
  5. Farkas, Josh MD. (2015). Table of Contents - EMCrit Project. EMCrit Project. https://emcrit.org/ibcc/toc/
Back to ABG Panel All Lab Values